Aliskiren an oral direct renin inhibitor

被引：0
|
作者：
Hermanowicz, Justyna M. [1 ]
Buczko, Wlodzimierz [1 ]
机构：
[1] Uniwersytet Medyczny, Zaklad Farmakodynamiki, PL-15222 Bialystok, Poland
来源：
KARDIOLOGIA POLSKA | 2008年 / 66卷 / 10期
关键词：
aliskiren; rennin inhibitor;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The authors described the pharmacological properties of aliskiren - the first renin inhibitor. The pharmacokinetis of aliskiren after oral administration in humans, its interaction with other hypotensive drugs and therapeutic significance are also described. The present data indicate that aliskiren can be useful as an alternative tool in the treatment of hypertension in patients who do not tolerate converting enzyme inhibitors or angiotension AT(1) receptor blockers.
引用
收藏
页码：S358 / S361
页数：4
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor
    Buczko, Wlodzimierz
    Hermanowicz, Justyna M.
    PHARMACOLOGICAL REPORTS, 2008, 60 (05) : 623 - 631
  • [2] Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension
    Sanoski, Cynthia A.
    PHARMACOTHERAPY, 2009, 29 (02): : 193 - 212
  • [3] Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension
    Verdecchia, Paolo
    Calvo, Carlos
    Moeckel, Volker
    Keeling, Lucy
    Satlin, Andrew
    BLOOD PRESSURE, 2007, 16 (06) : 381 - 391
  • [4] Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
    McMurray, John J. V.
    Pitt, Bertram
    Latini, Roberto
    Maggioni, Aldo P.
    Solomon, Scott D.
    Keefe, Deborah L.
    Ford, Jessica
    Verma, Anil
    Lewsey, Jim
    CIRCULATION-HEART FAILURE, 2008, 1 (01) : 17 - 24
  • [5] Aliskiren: The first direct renin inhibitor for hypertension
    van den Meiracker A.H.
    Danser A.H.J.
    Current Cardiology Reports, 2007, 9 (6) : 470 - 476
  • [6] Suppression of the renin system with the oral direct renin inhibitor aliskiren alone and in combination with valsartan in patients with hypertension
    Yarows, S. A.
    Oparil, S.
    Patel, S.
    Zhang, J.
    Fang, H.
    Satlin, A.
    JOURNAL OF HYPERTENSION, 2007, 25 : S257 - S258
  • [7] Safety, tolerability and pharmacokinetics of the oral direct renin inhibitor aliskiren in patients with hepatic impairment
    Vaidyanathan, Sujata
    Warren, Vance
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1072 - 1072
  • [8] Pharmacokinetics, safety and tolerability of the novel oral direct renin inhibitor aliskiren in elderly subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1072 - 1072
  • [9] Pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with irbesartan in renal impairment
    Vaidyanathan, Sujata
    Bigler, Hilde
    Yeh, ChingMing
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    CLINICAL PHARMACOKINETICS, 2007, 46 (08) : 661 - 675
  • [10] Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren Alone and in Combination with Irbesartan in Renal Impairment
    Sujata Vaidyanathan
    Hilde Bigler
    Ching Ming Yeh
    Marie-Noelle Bizot
    Hans Armin Dieterich
    Dan Howard
    William P. Dole
    Clinical Pharmacokinetics, 2007, 46 : 661 - 675
12345